High-content food liposome and preparation method thereof

By using a high-content food liposome formulation and a high-pressure homogenization process, the problems of low drug loading and low encapsulation efficiency of traditional liposomes have been solved, achieving improved encapsulation efficiency and particle size stability under high drug loading, making it suitable for the food industry.

CN121313561APending Publication Date: 2026-01-13EFFEPHARM (SHANGHAI) CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202511619556.3
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2025-11-06
Publication Date
2026-01-13

AI Technical Summary

Technical Problem

Traditional liposomes have a drug loading capacity of no more than 5%, and the drug loading capacity and encapsulation efficiency are negatively correlated. Furthermore, the animal source of cholesterol limits its application in the food industry, and long-term intake may affect human cholesterol metabolism.

Method used

A high-content food liposome formulation is used, including active ingredients, phospholipids, gum arabic, β-sitosterol, emulsifiers, and pH adjusters. Combined with ethanol injection and high-pressure homogenization, the homogenization pressure and number of times are controlled to form a dense liposome membrane, improving the encapsulation rate and stability.

Benefits of technology

It significantly improves the encapsulation efficiency and stability of liposomes, with uniform particle size distribution, making it suitable for large-scale preparation of food-grade liposomes and avoiding the metabolic risks of cholesterol.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN121313561A_ABST
    Figure CN121313561A_ABST
Patent Text Reader

Abstract

The invention relates to the field of food, in particular to a high-content food liposome and a preparation method thereof. The invention provides a high-content food liposome which comprises the following raw materials in parts by weight: 20-50 parts of an active component; 40-50 parts by weight of phospholipid; 5-20 parts by weight of Arabic gum; 5 to 20 parts by weight of beta-sitosterol; 0.1 to 1.0 part by weight of an emulsifier; and 0-0.5 part by weight of a pH regulator. The beta-sitosterol is introduced and matched with the Arabic gum and the emulsifier, the beta-sitosterol plays a role in stabilizing a film and improving rigidity, the Arabic gum plays a role in a freeze-drying protective agent and also serves as a wall material to play a role in stabilizing active ingredients to form a compact protective layer, and the emulsifier plays a role in stabilizing an interface and reducing interfacial tension. The compactness and the stability of a liposome membrane are comprehensively and synergistically enhanced, the encapsulation efficiency of active ingredients under a high drug loading condition is remarkably improved, and leakage in storage and gastrointestinal tract relief is reduced.
Need to check novelty before this filing date? Find Prior Art

Description

TECHNICAL FIELD

[0001] The present application relates to the field of food, in particular to a high-content food liposome and a preparation method. BACKGROUND

[0002] Liposomes are nanoscale vesicles composed of phospholipid bilayers, which have good biocompatibility and encapsulation capacity, and are widely used in food, medicine and other fields. The drug loading capacity of traditional liposomes is generally not higher than 5%, while the recommended daily consumption of supplements is generally about 100 mg. The drug loading capacity and the encapsulation efficiency of liposomes are negatively correlated, and as the drug loading capacity increases, the encapsulation efficiency decreases. In addition, cholesterol is often used as a liposome membrane stabilizer, but its animal origin may limit its application in the food field, and long-term intake may affect human cholesterol metabolism. SUMMARY

[0003] The present application provides a high-content food liposome and a preparation method to solve the problems of low drug loading capacity and low encapsulation efficiency of liposomes.

[0004] To this end, the present application provides the following technical solutions: In a first aspect, the present application provides a high-content food liposome, which is prepared from the following raw materials by weight: active ingredients, 20-50 parts by weight; phospholipids, 40-50 parts by weight; gum arabic, 5-20 parts by weight; beta-sitosterol, 5-20 parts by weight; emulsifiers, 0.1-1.0 parts by weight; pH adjuster, 0-0.5 parts by weight.

[0005] In some embodiments, the active ingredients include fat-soluble nutrients or water-soluble nutrients.

[0006] In some embodiments, the fat-soluble nutrients include one of resveratrol, silymarin, quercetin, curcumin, fisetin, VD3, coenzyme Q10; In some embodiments, the water-soluble nutrients include one of VC, glutathione, NMN.

[0007] In some embodiments, the emulsifier is selected from any one of propylene glycol, caprylic acid glyceride, capric acid glyceride, glycerol, glycerol monostearate, polyglycerol fatty acid ester, Tween, glycerol monolinoleate, glyceryl triacetate, PEG-40 hydrogenated castor oil, vitamin E succinate polyethylene glycol ester.

[0008] In some embodiments, the phospholipid is selected from at least one of sunflower phospholipid, soybean phospholipid, egg yolk phospholipid, or hydrogenated phospholipid. And / or, the pH regulator is selected from at least one of citric acid, phosphoric acid, or acetic acid.

[0009] In some embodiments, further comprising 400-2500 parts by weight of water phase solvent, and 40-50 parts by weight of lipid phase solvent.

[0010] In some embodiments, the water phase solvent is purified water.

[0011] In some embodiments, the lipid phase solvent is ethanol.

[0012] In a second aspect, the present application provides a method for preparing high content food liposome as described above, when the active ingredient is a fat-soluble nutrient, comprising the following steps: According to the formula, dissolve the phospholipid, beta-sitosterol, emulsifier, and fat-soluble nutrient to form a lipid phase; According to the formula, dissolve the gum arabic and pH regulator to form an aqueous phase; Inject the lipid phase into the aqueous phase to obtain a liposome suspension; Homogenize the liposome suspension and freeze-dry it; Or When the active ingredient is a water-soluble nutrient, comprising the following steps: According to the formula, dissolve the phospholipid and beta-sitosterol to form a lipid phase; According to the formula, dissolve the water-soluble nutrient, gum arabic, emulsifier, and pH regulator to form an aqueous phase; Inject the lipid phase into the aqueous phase to obtain a liposome suspension; Homogenize the liposome suspension and freeze-dry it.

[0013] In the method for preparing high content food liposome when the active ingredient is a water-soluble nutrient, the water-soluble nutrient can be encapsulated inside the liposome. The principle is mainly as follows: the inner core of the liposome contains part of the aqueous phase, because a part of the aqueous phase (containing water-soluble nutrients) is encapsulated during the formation of the liposome suspension; in addition, a concentration gradient is formed inside and outside the phospholipid bilayer, and the water-soluble nutrient will spontaneously enter the inner core of the liposome along the concentration gradient.

[0014] In some embodiments, in the step of forming the lipid phase, a lipid phase solvent is used for dissolution; And / or, in the step of forming the aqueous phase, an aqueous phase solvent is used for dissolution.

[0015] In some embodiments, the homogenization conditions are: homogenization pressure 200-1200 bar, homogenization cycles 1-5 times, and a material-to-liquid mass ratio of 1:5-1:25. The material-to-liquid ratio is the mass ratio of the material to the solvent. The material includes the sum of the masses of the active ingredient, phospholipids, gum arabic, β-sitosterol, emulsifier, and pH adjuster. The solvent is the sum of the masses of the aqueous phase solvent and the lipid phase solvent.

[0016] In some embodiments, the homogenization conditions are: homogenization pressure of 400 bar, homogenization times of 2, material-to-liquid mass ratio of 1:15, and β-sitosterol addition of 10 wt%.

[0017] In some embodiments, the freeze-drying conditions are as follows: First stage: -45~-35℃, 2~6h; Second stage: -25~-15℃, 2~6h; Third stage: -15~-5℃, 2~6h; Fourth stage: 0~10℃, 2~6h; Fifth stage: 5~15℃, 2~6h; Sixth stage: 15~25℃, 2~6h; Seventh stage: 25~35℃, 20~60h; Vacuuming begins from the second stage, and the freeze-drying ends when: vacuum degree ≤ 5Pa, material temperature ≥ 25℃.

[0018] Preferably, the freeze-drying conditions are as follows: First stage: -40℃, 4h; Second stage: -20℃, 2~6h; Third stage: -10℃, 2~6h; Fourth stage: 5℃, 2~6h; Fifth stage: 10℃, 2~6h; Sixth stage: 20℃, 2~6h; Seventh stage: 30℃, 20~60h; Vacuuming begins from the second stage, and the freeze-drying ends under the following conditions: vacuum degree ≤ 5Pa, material temperature ≥ 25℃.

[0019] The technical solution of this invention has the following advantages: 1. This invention provides a high-content food liposome, comprising the following raw materials in parts by weight: active ingredient, 20-50 parts by weight; phospholipid, 40-50 parts by weight; gum arabic, 5-20 parts by weight; β-sitosterol, 5-20 parts by weight; emulsifier, 0.1-1.0 parts by weight; pH adjuster, 0-0.5 parts by weight. This invention has found that when the proportion of active ingredient is significantly increased to approximately 20% or more, existing liposome systems struggle to maintain high encapsulation efficiency, leading to drug leakage and structural instability. Further research in this invention has revealed that by introducing β-sitosterol, combined with gum arabic and an emulsifier, β-sitosterol can reduce the permeability of the phospholipid bilayer, enhance its mechanical and thermal stability, inhibit membrane damage caused by external factors such as ultrasound and oxidation, and thus play a role in membrane stabilization and rigidity enhancement. In addition, β-sitosterol is similar to cholesterol in its steroidal skeleton and side chain configuration. It can restrict the movement of acyl chains and enhance molecular order in liposome membranes, thereby reducing membrane permeability and solute leakage, and improving resistance to ultrasound and oxidative stress. Gum arabic can form a continuous film on the surface of liposomes, which can significantly reduce the damage to liposomes caused by external temperature, humidity, acid and alkali and oxygen, and maintain the activity of nutrients and flavor stability. Its molecules possess both hydrophilic polysaccharide chains and a small number of hydrophobic / protein fragments, which facilitates directional adsorption at the phospholipid bilayer interface, forming a dense protective layer. In this case, gum arabic acts as both a freeze-drying protectant and a wall material, stabilizing the active ingredients and forming a dense protective layer. The emulsifier stabilizes the interface and reduces interfacial tension. For water-soluble nutrients, the emulsifier helps expand the effective volume of the aqueous phase within the liposome and inhibits leakage. For fat-soluble nutrients, it promotes their distribution and loading at the lipid interface, improving encapsulation efficiency and stability. This comprehensive and synergistic effect enhances the density and particle size stability of the liposome membrane, significantly improving the encapsulation rate of active ingredients under high drug loading conditions and reducing leakage during storage and gastrointestinal remission.

[0020] Furthermore, β-sitosterol is a plant sterol that meets food-grade safety requirements. It has a structure similar to cholesterol, but has health benefits such as regulating blood lipids and reducing cholesterol absorption, thus avoiding the metabolic risks associated with animal-derived cholesterol.

[0021] 2. The present invention provides a method for preparing high-content food liposomes, wherein the method employs an ethanol injection method combined with a high-pressure homogenization process, controlling the homogenization pressure at 200~1200 bar, homogenizing 1~5 times, and a material-liquid ratio of 1:5~1:25, so that the liposome particle size distribution is more uniform, the average particle size is less than 100-500 nm, and the encapsulation efficiency is significantly improved.

[0022] 3. The present invention provides a method for preparing high-content food liposomes, wherein the homogenization conditions are: homogenization pressure of 400 bar, homogenization times of 2 times, material-to-liquid ratio of 1:15, and β-sitosterol addition of 10 wt%. The present invention has found that the combined effect of β-sitosterol and homogenization conditions on the compactness and particle size distribution of liposome membranes is significant. When the β-sitosterol content is 10 wt%, under a homogenization pressure of 400 bar, it can effectively promote the orderly arrangement of phospholipid molecules, reduce membrane defects, improve encapsulation efficiency, and result in a uniform and concentrated particle size distribution. These conditions, while ensuring high drug loading, significantly enhance the storage stability and gastrointestinal tolerance of the formulation, making it suitable for large-scale preparation of food-grade liposomes. Attached Figure Description

[0023] To more clearly illustrate the specific embodiments of the present invention or the technical solutions in the prior art, the drawings used in the description of the specific embodiments or the prior art will be briefly introduced below. Obviously, the drawings described below are some embodiments of the present invention. For those skilled in the art, other drawings can be obtained from these drawings without creative effort.

[0024] Figure 1 These are the contour plots and response surface plots of homogenization times and homogenization pressure in Experiment Example 6 of this invention; Figure 2 These are the contour plots and response surface plots of the feed-liquid ratio and homogenization pressure in Experiment Example 6 of this invention; Figure 3 These are the contour plots and response surface plots of β-sitosterol addition amount and homogenization pressure in Experimental Example 6 of this invention; Figure 4 These are contour plots and response surface plots of the material-liquid ratio and homogenization times in Experiment Example 6 of this invention; Figure 5 These are contour plots and response surface plots of the amount of β-sitosterol added and the number of homogenization times in Experiment Example 6 of this invention; Figure 6 These are contour plots and response surface plots of the β-sitosterol addition amount and the material-liquid ratio in Experimental Example 6 of this invention. Detailed Implementation The following embodiments are provided to better understand the present invention, but the following embodiments do not constitute a limitation on the content and scope of protection of the present invention. Any product that is the same as or similar to the present invention, derived by any person under the guidance of the present invention or by combining the features of the present invention with other prior art, falls within the scope of protection of the present invention.

[0025] Unless otherwise specified, all experimental steps or conditions in the examples were performed according to conventional experimental procedures and conditions in the art. Reagents or instruments whose manufacturers are not specified are all commercially available products.

[0026] The ethanol used in the following implementations is of analytical grade.

[0027] Example 1 This embodiment provides a high-content food liposome with the following formulation: Resveratrol 30g, sunflower phospholipids 45g, gum arabic 15g, β-sitosterol 10g, Tween 80 0.1g, citric acid 0.1g, ethanol 80g, purified water 1420g.

[0028] The preparation method includes the following steps: According to the formula, phospholipids, β-sitosterol, Tween 80 and resveratrol are dissolved in ethanol to form a lipid phase; According to the formula, gum arabic and citric acid are dissolved in water to form an aqueous phase; The lipid phase was injected into the aqueous phase to obtain a liposome suspension; The liposome suspension was homogenized at a pressure of 400 bar twice. It was then freeze-dried under the following conditions: Stage 1: -40℃, 4h; Stage 2: -20℃, 4h; Stage 3: -10℃, 4h; Stage 4: 5℃, 4h; Stage 5: 10℃, 4h; Stage 6: 20℃, 4h; Stage 7: 30℃, 40h. Vacuum was applied starting from Stage 2. The freeze-drying ended with a vacuum degree ≤ 5 Pa and a material temperature ≥ 25℃.

[0029] Example 2 This embodiment provides a high-content food liposome with the following formulation: Resveratrol 20g, sunflower phospholipids 50g, gum arabic 5g, β-sitosterol 20g, Tween 80 0.1g, citric acid 0.5g, ethanol 40g, purified water 2500g.

[0030] The preparation method includes the following steps: According to the formula, phospholipids, β-sitosterol, Tween 80 and resveratrol are dissolved in ethanol to form a lipid phase; According to the formula, gum arabic and citric acid are dissolved in water to form an aqueous phase; The lipid phase was injected into the aqueous phase to obtain a liposome suspension; The liposome suspension was homogenized at a pressure of 1200 bar, once. It was then freeze-dried under the following conditions: Stage 1: -45℃, 2h; Stage 2: -25℃, 2h; Stage 3: -15℃, 2h; Stage 4: 0℃, 2h; Stage 5: 5℃, 2h; Stage 6: 15℃, 2h; Stage 7: 25℃, 20h. Vacuum was applied starting from Stage 2. The freeze-drying ended with a vacuum degree ≤ 5 Pa and a material temperature ≥ 25℃.

[0031] Example 3 This embodiment provides a high-content food liposome with the following formulation: Resveratrol 50g, sunflower phospholipids 40g, gum arabic 20g, β-sitosterol 5g, Tween 80 1.0g, citric acid 0.5g, ethanol 50g, purified water 400g.

[0032] The preparation method includes the following steps: According to the formula, phospholipids, β-sitosterol, Tween 80 and resveratrol are dissolved in ethanol to form a lipid phase; According to the formula, gum arabic and citric acid are dissolved in water to form an aqueous phase; The lipid phase was injected into the aqueous phase to obtain a liposome suspension; The liposome suspension was homogenized at a pressure of 1200 bar for 5 cycles, followed by freeze-drying under the following conditions: Stage 1: -35℃, 6 h; Stage 2: -15℃, 6 h; Stage 3: -5℃, 6 h; Stage 4: 10℃, 6 h; Stage 5: 15℃, 6 h; Stage 6: 25℃, 6 h; Stage 7: 35℃, 60 h. Vacuum was applied starting from Stage 2, and the freeze-drying ended when the vacuum level was ≤5 Pa and the material temperature was ≥25℃.

[0033] Example 4 The difference between this embodiment and Embodiment 1 is that resveratrol is replaced with silymarin in equal amounts, sunflower phospholipids are replaced with soybean phospholipids in equal amounts, and Tween 80 is replaced with polyglycerol fatty acid esters in equal amounts.

[0034] Example 5 The difference between this embodiment and Embodiment 1 is that resveratrol is replaced with quercetin in equal amounts, sunflower phospholipids are replaced with egg yolk phospholipids in equal amounts, and Tween 80 is replaced with glyceryl monostearate in equal amounts.

[0035] Example 6 The difference between this embodiment and Example 1 is that resveratrol is replaced with curcumin in equal amounts, sunflower phospholipids are replaced with hydrogenated phospholipids in equal amounts, and Tween 80 is replaced with PEG-40 hydrogenated castor oil in equal amounts.

[0036] Example 7 The difference between this embodiment and Embodiment 1 is that resveratrol is replaced with an equal amount of flavonoids, and Tween 80 is replaced with an equal amount of Tween 20.

[0037] Example 8 The difference between this embodiment and Embodiment 1 is that resveratrol is replaced with an equal amount of vitamin D3 (VD3), and Tween 80 is replaced with an equal amount of caprylic / capric triglyceride.

[0038] Example 9 The difference between this embodiment and Example 1 is that resveratrol is replaced with coenzyme Q10 in equal amounts, and Tween 80 is replaced with triacetylglycerol in equal amounts.

[0039] Example 10 This embodiment provides a high-content food liposome with the following formulation: Vitamin C (VC) 30g, sunflower phospholipids 45g, gum arabic 15g, β-sitosterol 10g, propylene glycol 0.5g, citric acid 0.3g, ethanol 80g, purified water 1500g.

[0040] The preparation method includes the following steps: According to the formula, phospholipids and β-sitosterol are dissolved in ethanol to form a lipid phase; According to the formula, vitamin C, gum arabic, propylene glycol and citric acid are dissolved in water to form an aqueous phase; The lipid phase was injected into the aqueous phase to obtain a liposome suspension; The liposome suspension was homogenized at a pressure of 400 bar twice. It was then freeze-dried under the following conditions: Stage 1: -40℃, 4h; Stage 2: -20℃, 4h; Stage 3: -10℃, 4h; Stage 4: 5℃, 4h; Stage 5: 10℃, 4h; Stage 6: 20℃, 4h; Stage 7: 30℃, 40h. Vacuum was applied starting from Stage 2. The freeze-drying ended with a vacuum degree ≤ 5 Pa and a material temperature ≥ 25℃.

[0041] Example 11 This embodiment provides a high-content food liposome with the following formulation: Glutathione 20g, sunflower phospholipids 50g, gum arabic 5g, β-sitosterol 20g, glycerol 0.1g, citric acid 0.5g, ethanol 40g, purified water 400g.

[0042] The preparation method includes the following steps: According to the formula, phospholipids and β-sitosterol are dissolved in ethanol to form a lipid phase; According to the formula, glutathione, gum arabic, glycerin and citric acid are dissolved in water to form an aqueous phase; The lipid phase was injected into the aqueous phase to obtain a liposome suspension; The liposome suspension was homogenized at a pressure of 400 bar, and homogenized twice. It was then freeze-dried under the following conditions: Stage 1: -45℃, 2h; Stage 2: -25℃, 2h; Stage 3: -15℃, 2h; Stage 4: 0℃, 2h; Stage 5: 5℃, 2h; Stage 6: 15℃, 2h; Stage 7: 25℃, 20h. Vacuum was applied starting from Stage 2. The freeze-drying ended when the vacuum level was ≤5Pa and the material temperature was ≥25℃.

[0043] Example 12 50g of β-nicotinamide mononucleotide (NMN), 40g of sunflower phospholipids, 20g of gum arabic, 5g of β-sitosterol, 0.1g of polyethylene glycol succinate, 0.5g of citric acid, 50g of ethanol, and 2500g of purified water.

[0044] The preparation method includes the following steps: According to the formula, phospholipids and β-sitosterol are dissolved in ethanol to form a lipid phase; According to the formula, NMN, gum arabic, vitamin E succinate polyethylene glycol ester and citric acid are dissolved in water to form an aqueous phase; The lipid phase was injected into the aqueous phase to obtain a liposome suspension; The liposome suspension was homogenized at a pressure of 400 bar twice, followed by freeze-drying under the following conditions: Stage 1: -35℃, 6 h; Stage 2: -15℃, 6 h; Stage 3: -5℃, 6 h; Stage 4: 10℃, 6 h; Stage 5: 15℃, 6 h; Stage 6: 25℃, 6 h; Stage 7: 35℃, 60 h. Vacuum was applied starting from Stage 2, and the freeze-drying ended when the vacuum level was ≤5 Pa and the material temperature was ≥25℃.

[0045] Comparative Example 1 The difference between this comparative example and Example 1 is that gum arabic is replaced with an equal amount of lactose.

[0046] Comparative Example 2 The difference between this comparative example and Example 1 is that gum arabic is replaced with an equal amount of mannitol.

[0047] Comparative Example 3 The difference between this comparative example and Example 1 is that gum arabic is replaced with an equal amount of maltodextrin.

[0048] Comparative Example 4 The difference between this comparative example and Example 1 is that gum arabic is omitted and replaced with an equal amount of β-sitosterol.

[0049] Comparative Example 5 The difference between this comparative example and Example 1 is that the emulsifier is omitted and Tween 80 is replaced with an equal amount of gum arabic.

[0050] Comparative Example 6 The difference between this comparative example and Example 1 is that β-sitosterol is replaced with cholesterol in equal amounts.

[0051] Experimental Example 1 This experiment examines the particle size distribution, encapsulation efficiency, and active ingredient content of high-content food liposomes prepared in Examples 1-12 and Comparative Examples 1-6.

[0052] Particle size distribution: Take 200 mg of liposome powder into a 10 mL centrifuge tube, add 10 mL of purified water, vortex for 5-10 min to disperse it evenly, filter through a 0.22 μm filter membrane to remove large particles, dilute with purified water 2-10 times and test using a DLS nanoparticle size potentiometer.

[0053] Determination of active ingredient content: Resveratrol: Based on "Preparation of Resveratrol Nanosuspension and its Inhibitory Effect on Cervical Cancer Cells"; Silymarin: According to "Q / YDTM 0007 S-2019 Health Food Raw Material Silymarin Extract"; Quercetin: According to T / CCCMHPIE 1.30-2018 Quercetin, a plant extract; Curcumin: According to GB 1886.76-2015 National Food Safety Standard - Food Additives - Curcumin; Rhubarb: Based on "Preparation of Rhubarb-loaded nanomicelles based on stevia and their anti-colitis activity"; VD3: According to GB 1903.50-2020 National Food Safety Standard for Food Fortifiers Cholecalciferol (Vitamin D3); Coenzyme Q10: According to GB / T 22252-2024 Determination of Coenzyme Q10 in Health Foods; VC: According to GB 14754-2010 National Food Safety Standard - Food Additives - Vitamin C (Ascorbic Acid) Glutathione: According to the Chinese Pharmacopoeia of Glutathione Tablets; NMN: Based on "Kinetic Study of Degradation of β-Nicotinamide Mononucleotide Based on Reliable HPLC Quantitative Method".

[0054] Encapsulation efficiency determination method: The membrane method is used, which is applicable to fat-soluble nutrients.

[0055] Weigh 1g of liposome powder into a 10mL centrifuge tube, add 10mL of purified water, vortex to mix, and this is solution A.

[0056] First, take 1 mL of solution A into a 100 mL volumetric flask, add ethanol, sonicate for 5 min to break the emulsion, and then dilute to the mark. Measure the peak area using HPLC; this is solution A. 总 .

[0057] Take an appropriate amount of solution A and filter it through a 0.22 μm aqueous microporous membrane. Take 1 mL of the subsequent filtrate (discard the initial 1 mL filtrate; the filter membrane should not be replaced during the process) into a 100 mL volumetric flask. Add ethanol, sonicate for 5 min to break the emulsion, and then dilute to the mark. Measure the peak area using HPLC; this is the value of solution A. 包 .

[0058] ; ; Ultrafiltration centrifugation is suitable for water-soluble nutrients.

[0059] Accurately weigh 1g of liposome powder and dissolve it in 10mL of purified water (shake by hand or gently vortex until there are no obvious particles in the solution) to obtain liposome solution A (the obtained solution should be sampled immediately for use in steps 1 and 2).

[0060] 1) Take 50 μL of solution A into a 1.5 mL centrifuge tube containing 100 μL of methanol, vortex for 5 min to break the emulsion, add 1 mL of purified water, vortex to mix, and then determine the peak area by HPLC. This peak area is A. 总 .

[0061] 2) Take 1 mL of solution A into an ultrafiltration centrifuge tube (10 kDa), centrifuge at 12000 rpm (4℃) for 5 min, filter, and take 50 μL of the filtrate into a 1.5 mL centrifuge tube containing 100 μL of methanol. Vortex for 5 min to break the emulsion, add 1 mL of purified water, vortex to mix, and then determine the peak area by HPLC. This peak area is solution A. 游 .

[0062]

[0063] ; The measurement results are shown in the table below: Table 1. Test Results

[0064] As can be seen from the above, the food liposome freeze-dried powders obtained in Examples 1-12 exhibit high encapsulation efficiency, stable particle size within 100-400 nm, low PDI, and uniformity under high active ingredient loading. In contrast, Comparative Examples 1-6, under high active ingredient loading, show low encapsulation efficiency, non-uniform and unstable particle size, high PDI, and larger particle size. This demonstrates that the components in the present invention have a synergistic effect, synergistically improving the encapsulation efficiency and particle size uniformity under high loading.

[0065] Experimental Example 2: Effect of Different Homogeneous Pressures Based on Example 1, the homogenization conditions were kept constant: homogenization twice, and a material-to-liquid ratio of 1:15. The formulation contained approximately 10 wt% β-sitosterol (solvent not included). Homogenization pressures of 200, 400, 600, 800, and 1000 bar were selected. Particle size and encapsulation efficiency were determined according to the method described in Example 1. The results are shown in the table below: Table 2 Effect of different homogeneous pressures

[0066] As shown in the table, the particle size of liposomal resveratrol gradually decreases with increasing homogenization pressure, while the encapsulation efficiency of liposomal resveratrol first increases and then decreases with increasing homogenization pressure. The maximum encapsulation efficiency of liposomal resveratrol is 74.06% when the homogenization pressure is 400 bar.

[0067] Experiment Example 3: Effect of Different Homogenization Times Based on Example 1, the homogenization conditions were fixed: homogenization pressure 200 bar, material-to-liquid ratio 1:10 (purified water adjusted to 920 g). The formulation contained approximately 5 wt% β-sitosterol (solvent not included; β-sitosterol was adjusted to 5 g, and sunflower phospholipids were increased to 50 g). Homogenization was performed 1, 2, 3, 4, and 5 times. Particle size and encapsulation efficiency were determined according to the method in Example 1. The results are shown in the table below: Table 3 Effect of different homogenization times

[0068] As shown in the table, the number of homogenization cycles has no significant effect on the particle size of liposomal resveratrol. The encapsulation efficiency of liposomal resveratrol first increases and then decreases with increasing homogenization cycles. The encapsulation efficiency of liposomal resveratrol is the highest at 63.45% when homogenized twice.

[0069] Experiment Example 4: Effect of Different Feed-to-Liquid Ratios Based on Example 1, the homogenization conditions were fixed: homogenization pressure 200 bar, homogenization once. The formulation contained approximately 5 wt% β-sitosterol (solvent not included; β-sitosterol was adjusted to 5 g, and sunflower phospholipids were increased to 50 g). The solid-liquid ratios were selected as 1:5, 1:10, 1:15, 1:20, and 1:25 (purified water was adjusted accordingly to 420 g, 920 g, 1420 g, 1920 g, and 2420 g). Particle size and encapsulation efficiency were determined according to the method in Example 1. The results are shown in the table below: Table 4 Effect of different feed-to-liquid ratios

[0070] As shown in the table, the particle size of liposomal resveratrol increases with decreasing material-to-liquid ratio, while the encapsulation efficiency first increases and then decreases with decreasing material-to-liquid ratio. The encapsulation efficiency of liposomal resveratrol is highest at a material-to-liquid ratio of 1:15, reaching 83.57%.

[0071] Experimental Example 5: Effect of Different Amounts of β-Sitosterol Added Based on Example 1, the homogenization conditions were fixed: homogenization pressure 200 bar, homogenization times 1, and a material-to-liquid ratio of 1:10 (purified water was adjusted to 920 g). The β-sitosterol (excluding solvent) in the formulation was selected at 5, 10, 15, 20, and 25 wt% respectively (β-sitosterol was adjusted to 5 g, sunflower phospholipid increased to 50 g; β-sitosterol was adjusted to 10 g, sunflower phospholipid 45 g; β-sitosterol was adjusted to 15 g, sunflower phospholipid 40 g; β-sitosterol was adjusted to 20 g, sunflower phospholipid 40 g, and gum arabic 10 g; β-sitosterol was adjusted to 25 g, sunflower phospholipid 40 g, and gum arabic 5 g). Particle size and encapsulation efficiency were determined according to the method in Example 1. The results are shown in the table below: Table 5. Effect of different β-sitosterol addition amounts

[0072] As shown in the table, the particle size of liposomal resveratrol first increases and then decreases with increasing β-sitosterol content, and the encapsulation efficiency of liposomal resveratrol first increases and then decreases with increasing β-sitosterol content. When the β-sitosterol content is 10 wt%, the encapsulation efficiency of liposomal resveratrol is the highest, at 37.34%.

[0073] Experiment Example 6: Box-Behnken Response Surface Optimization Based on the results of the single-factor experiments, the gradient range was narrowed to further optimize the liposome formulation and process. The factor level table is as follows.

[0074] Table 6 Factor Level Table

[0075] Based on the above factor level table, the prescription was designed using Design-Expert 13 software.

[0076] Table 7 Response Surface Experimentation Scheme and Results

[0077] Experiments were conducted based on the above formulation design, and the encapsulation efficiency results were entered into the table above. Design-Expert 13 software was used for model fitting and analysis of variance. The software-fitted equation is: EE% = 85.50 - 1.85A + 0.4517B - 0.99C - 2.44D - 3.08AB + 1.85AC + 2.75AD + 3.43BC + 2.91BD - 3.90CD - 10.59A 2 -8.26B 2 -8.07C 2 -11.60D 2 The analysis of variance is shown in the table below.

[0078] Table 7 Analysis of Variance Table

[0079] As shown in the table above, the F-value of the model is 34.12, indicating that the model is significant. A p-value < 0.05 indicates that each indicator in the model is significant, specifically A, D, AB, AD, BC, BD, CD, and A. 2 B 2 C 2 D 2 This is an important model term. The R-squared value of this model is... 2 =0.9715, indicating a high correlation between the predicted and actual values, and the predicted R-value is [value missing]. 2 =0.8386, compared with the adjusted R 2 The value of 0.9430 is consistent with the error of less than 0.2. The signal-to-noise ratio is 18.544 > 4, indicating that the model fits well and can be used to analyze and predict the actual situation of liposome encapsulation efficiency.

[0080] Figures 1-6 Contour plots and response surface plots show the interaction effects of various factors on liposome encapsulation efficiency. These plots provide a visual comparison of the influence of each individual factor on liposome encapsulation efficiency and the strength of their interactions. Steeper curves indicate a greater influence of the factor on liposome encapsulation efficiency. Elliptical contour lines representing interactions between factors indicate a strong interaction, while circular contour lines indicate a weaker interaction. The order of influence of each factor on liposome encapsulation efficiency is: feed-to-liquid ratio > homogenization cycles > β-sitosterol addition > homogenization pressure.

[0081] Example 7: Optimal Verification The optimal formulation process (homogenization pressure 400 bar, homogenization times 2, material-to-liquid ratio 1:15, β-sitosterol addition 10 wt%) optimized by Box-Behnken response surface methodology was experimentally validated. The software predicted an encapsulation efficiency of 85.8%, while the experimentally tested encapsulation efficiency was 88.30%, with an error of 2.91%, indicating that the model can accurately predict the liposome encapsulation efficiency.

[0082] Example 8: Comparative Experiment of β-Sitosterol and Cholesterol Based on the optimized process (based on Example 1), the effects of β-sitosterol and cholesterol on the encapsulation efficiency of different liposomes were compared. As shown in the table below, the encapsulation efficiency of fat-soluble nutrients is higher than that of water-soluble nutrients. The encapsulation efficiency of β-sitosterol is close to that of cholesterol, indicating that β-sitosterol can replace cholesterol in its role between the phospholipid bilayer.

[0083] Table 8 Comparison of the effects of β-sitosterol and cholesterol on liposome encapsulation efficiency

[0084] Obviously, the above embodiments are merely illustrative examples for clear explanation and are not intended to limit the implementation. Those skilled in the art will recognize that other variations or modifications can be made based on the above description. It is neither necessary nor possible to exhaustively list all possible implementations here. However, obvious variations or modifications derived therefrom are still within the scope of protection of this invention.

Claims

1. A high-content food liposome, characterized in that, It is made from the following raw materials in parts by weight: Active ingredient, 20-50 parts by weight; Phospholipids, 40-50 parts by weight; Gum arabic, 5-20 parts by weight; β-sitosterol, 5-20 parts by weight; Emulsifier, 0.1~1.0 parts by weight; pH adjuster, 0~0.5 parts by weight.

2. The high-content food liposomes according to claim 1, characterized in that, The active ingredients include fat-soluble nutrients or water-soluble nutrients; The fat-soluble nutrients include one of the following: resveratrol, silymarin, quercetin, curcumin, rosin, vitamin D3, and coenzyme Q10. The water-soluble nutrients include one of vitamin C, glutathione, and NMN.

3. The high-content food liposomes according to claim 1 or 2, characterized in that, The emulsifier is selected from any one of propylene glycol, caprylic / capric glyceride, glycerol, glyceryl monostearate, polyglycerol fatty acid ester, Tween derivatives, glyceryl monolinoleate, glyceryl triacetate, PEG-40 hydrogenated castor oil, and polyethylene glycol succinate.

4. The high-content food liposomes according to any one of claims 1-3, characterized in that, The phospholipid is selected from at least one of sunflower phospholipid, soybean phospholipid, egg yolk phospholipid, or hydrogenated phospholipid; And / or, the pH adjuster is selected from at least one of citric acid, phosphoric acid, or acetic acid.

5. The high-content food liposomes according to any one of claims 1-4, characterized in that, It also includes 400-2500 parts by weight of aqueous phase solvent and 40-80 parts by weight of lipid phase solvent; And / or, the aqueous phase solvent is purified water; And / or, the lipid phase solvent is ethanol.

6. A method for preparing high-content food liposomes as described in any one of claims 1-5, characterized in that, Includes the following steps: According to the formula, phospholipids, β-sitosterol, emulsifiers and fat-soluble nutrients are dissolved to form a lipid phase; According to the formula, dissolve gum arabic and pH adjuster to form an aqueous phase; The lipid phase was injected into the aqueous phase to obtain a liposome suspension; The liposome suspension was homogenized and freeze-dried. or According to the formula, phospholipids and β-sitosterol are dissolved to form a lipid phase; According to the formula, water-soluble nutrients, gum arabic, emulsifier and pH adjuster are dissolved to form an aqueous phase; The lipid phase was injected into the aqueous phase to obtain a liposome suspension; The liposome suspension was homogenized and freeze-dried.

7. The method for preparing high-content food liposomes according to claim 6, characterized in that, In the step of forming the lipid phase, a lipid phase solvent is used for dissolution; And / or, in the step of forming the aqueous phase, an aqueous solvent is used for dissolution.

8. The method for preparing high-content food liposomes according to claim 6 or 7, characterized in that, The homogenization conditions are: homogenization pressure 200-1200 bar, homogenization times 1-5 times, and material-liquid mass ratio 1:5-1:

25.

9. The method for preparing high-content food liposomes according to any one of claims 6-8, characterized in that, The homogenization conditions are as follows: homogenization pressure of 400 bar, homogenization times of 2, material-to-liquid mass ratio of 1:15, and β-sitosterol addition of 10 wt%.

10. The method for preparing high-content food liposomes according to any one of claims 6-9, characterized in that, The freeze-drying conditions are as follows: Stage 1: -45~-35℃, 2~6h; Stage 2: -25~-15℃, 2~6h; Stage 3: -15~-5℃, 2~6h; Stage 4: 0~10℃, 2~6h; Stage 5: 5~15℃, 2~6h; Stage 6: 15~25℃, 2~6h; Stage 7: 25~35℃, 20~60h; Vacuuming begins from the second stage, and the freeze-drying ends when: vacuum degree ≤ 5Pa, material temperature ≥ 25℃. Preferably, the freeze-drying conditions are as follows: First stage: -40℃, 4h; Second stage: -20℃, 2~6h; Third stage: -10℃, 2~6h; Fourth stage: 5℃, 2~6h; Fifth stage: 10℃, 2~6h; Sixth stage: 20℃, 2~6h; Seventh stage: 30℃, 20~60h; Vacuuming begins from the second stage, and the freeze-drying ends under the following conditions: vacuum degree ≤ 5Pa, material temperature ≥ 25℃.